logo
About Contact

Ex-OpenAI Leaders Secure $215 Million to Revolutionize Drug Research with AI Technology

Technology News

Ex-OpenAI Leaders Secure $215 Million to Revolutionize Drug Research with AI Technology

Former OpenAI Exec Raises $215 Mn to Build AI-Powered Drug Research Labs

AIM

Former OpenAI Exec Raises $215 Mn to Build AI-Powered Drug Research Labs

Warp Sciences will initially focus on synthesising molecular variations for drug candidates, combining chemists, robotics, and AI models trained on laboratory experiments.

Ex-OpenAI Science Head Launches Startup With $215 Million

Bloomberg

Ex-OpenAI Science Head Launches Startup With $215 Million

Kevin Weil, the former OpenAI executive who led the ChatGPT maker’s AI-for-science efforts, is launching a new startup aimed at using artificial intelligence to speed up a key step of drug...

Ex-OpenAI’s Kevin Weil, Former Meta AI leader Manohar Paluri's startup bags $215 million from...

MoneyControl

Ex-OpenAI’s Kevin Weil, Former Meta AI leader Manohar Paluri's startup bags $215 million from...

Warp Sciences brings expert chemists, AI, and robotics together to help biotech and pharma firms speed up drug discovery

Former OpenAI science lead launches Warp Science to automate wet labs with robots

TechCrunch

Former OpenAI science lead launches Warp Science to automate wet labs with robots

Wearing cameras and sensor gloves, the startup’s human chemists will train robots to perform various lab tasks.

Coverage dates

First reported:

First saved on ClustZ:

Coverage updated:

We use cookies to improve your experience and analyze site traffic. By clicking "Accept", you agree to our use of cookies. See our Privacy Policy.